Jump to main content
Jump to site search

Volume 187, 2016
Previous Article Next Article

Toward SERS-based point-of-care approaches for therapeutic drug monitoring: the case of methotrexate

Author affiliations

Abstract

To date, in spite of their toxicity, the plasmatic concentration of most chemotherapeutic drugs is difficult to monitor in oncological patients, because their quantitative determination is expensive and time consuming. This contribution reports a first attempt for the direct quantitative determination of a chemotherapeutic drug in human serum samples by means of Surface Enhanced Raman Spectroscopy (SERS). In this study, SERS substrates constituted by Au nanoparticles deposited on paper by a simple dipping method have been used for rapid (few minutes) analysis of diluted human serum spiked with different concentrations of methotrexate, MTX. The drug concentrations were chosen in a range designed to cover typical therapeutic plasmatic values (from nanomolar to millimolar) in oncological patients, and the pertinent calibration was obtained by Partial Least-Squares Regression (PLSR). Stability selection was employed to evaluate the capability of the PLSR model to accurately predict and extract spectral variations correlated to MTX concentration. Such a quantitative determination is crucial for frequent, and hence adherent, therapeutic drug monitoring, TDM, of chemiotherapic drugs, given their heavy side effects. Its low cost, rapid response and the possibility of obtaining spectra with simple and compact instruments, make SERS particularly apt for implementing effective TDM. The promising results obtained in the analytical validation indicate which steps are to be taken on the way toward a clinical validation with real samples from oncological patients, for MTX as well as for other chemotherapeutic drugs.

Back to tab navigation

Supplementary files

Publication details

The article was received on 16 Nov 2015, accepted on 08 Jan 2016 and first published on 07 Apr 2016


Article type: Paper
DOI: 10.1039/C5FD00173K
Author version
available:
Download author version (PDF)
Faraday Discuss., 2016,187, 485-499

  •   Request permissions

    Toward SERS-based point-of-care approaches for therapeutic drug monitoring: the case of methotrexate

    S. Fornasaro, S. D. Marta, M. Rabusin, A. Bonifacio and V. Sergo, Faraday Discuss., 2016, 187, 485
    DOI: 10.1039/C5FD00173K

Search articles by author

Spotlight

Advertisements